|
Published by: SMI Publishing, Ltd
Published: Apr. 16, 2012
Table of Contents- Day 1
- 8:30
- Registration & Coffee
- 9:00
- Chairman's Opening Remarks
- Sebastian Johnston, Professor of Respiratory Medicine, Imperial College School of Medicine (N.H.L.I.)
- 9:10
- Comparing exacerbations of Asthma & COPD
- Sebastian Johnston, Professor of Respiratory Medicine, Imperial College School of Medicine (N.H.L.I.)
- 9:50
- Unmet Challenges in Asthma
- Samantha Walker, Executive Director, Research & Policy, Asthma Uk
- 10:30
- Morning Coffee
- 11:00
- CHEMOKINE RECEPTOR CXCR2 ANTAGONISM TO PREVENT AIRWAYS INFLAMMATION
- Louise Donnelly, Reader in Respiratory Cell Biology, National Heart and Lung Institute Imperial College
- 11:40
- CRTH2 antagonists for the treatment of asthma and allergic rhinitis
- Roy Pettipher, , Oxagen Ltd
- 12:20
- Combination therapy
- Mary Fitzgerald, Research, Pulmagen Therapeutics
- 13:00
- Networking Lunch
- 14:00
- Novel Data from Asthma Clinical Trials
- Ewan Walters, Medical Director, Teva UK Ltd
- 14:40
- Anti-inflammatory therapies in COPD
- Daniel Bock, Chief Scientific Officer, Revotar Biopharmaceuticals
- 15:20
- Afternoon Tea
- 15:40
- MyAsthma: lessons from a live app for asthma patients
- Francisco Abad-Marin, Marketing Manager, Respiratory Centre of Excellence, GlaxoSmithKline
- 15:40
- MyAsthma: lessons from a live app for asthma patients
- Nick Broughton, Consultant Medical Advisor, GSK
- 16:20
- Panel Discussion: Asthma mechanisms & treatments : Featuring a selection of the day's speakers
- Sebastian Johnston, Professor of Respiratory Medicine, Imperial College School of Medicine (N.H.L.I.)
- 16:20
- Panel Discussion: Asthma mechanisms & treatments : Featuring a selection of the day's speakers
- Roy Pettipher, , Oxagen Ltd
- 16:20
- Panel Discussion: Asthma mechanisms & treatments : Featuring a selection of the day's speakers
- Stefano Petruzzelli, Head of Respiratory Medicine unit, CHIESI FARMACEUTICI S.P.A.
- 17:00
- Chairman’s Closing Remarks and Close of Day One
- Day 2
- 8:30
- Registration & Coffee
- 9:00
- Chairman's Opening Remarks
- Peter Barnes, Head of Respiratory Medicine, Imperial College
- 9:10
- The problem of steroid resistance in Asthma & COPD
- Peter Barnes, Head of Respiratory Medicine, Imperial College
- 9:50
- Using patient reported outcomes (CCQ ACQ) in daily clinical practice; results of the asthma COPD service for General practitioners in The Netherlands
- Thys van der Molen, Professor of primary care Respiratory Medicine, University of Groningen University Medical Centre Groningen Centre for Medical Biomics
- 10:30
- Morning Coffee
- 11:00
- The challenge of COPD exacerbations: how do Patient Reported Outcomes impact in clinical trials design?
- Stefano Petruzzelli, Head of Respiratory Medicine unit, CHIESI FARMACEUTICI S.P.A.
- 11:40
- Co-Morbidities in COPD
- John Hurst, Senior Clinical Lecturer, University College London
- 12:20
- Development of a vagus nerve stimulator to treat asthma and COPD exacerbations. A game changing technology?
- Bruce Simon, VP Research, ElectroCore Medical, AB
- 13:00
- Networking Lunch
- 14:10
- The Management of COPD exacerbations
- Neil Barnes, Consultant Respiratory Physician, Barts & The London NHS Trust
- 14:50
- Pre-clinical models of asthma and COPD
- Maria Belvisi, Professor of Respiratory Pharmacology, National Heart and Lung Institute Imperial College London
- 15:30
- Afternoon Tea
- 15:50
- Patient stratification: lesions from clinical trials of biologic drugs in Asthma
- Matthew Catley, Head of Respiratory Pharmacology, UCB-Celltech
- 16:30
- Panel Discussion: COPD mechanisms & treatments : A selection of speakers from the day
- Peter Barnes, Head of Respiratory Medicine, Imperial College
- 17:00
- Chairman’s Closing Remarks and Close of Day Two
AbstractSMi present their 8th annual Asthma & COPD event to be held in London on Monday 16th & Tuesday 17th of Apil 2012. Building on the success of our previous Asthma & COPD, and COPD: Novel Therapeutics and Management Strategies events, this year will see an elite panel of speakers drawn for both industry and academia.
The successful combination of academic KOLs and leading senior big Pharma speakers offers an ideal and comprehensive platform for the study of both Asthma & COPD.
The similarities between the two conditions are juxtoposed with the the subtle and important differences. Both pose unique and complex challenges, and these differences must be identified and isolated. As respiratory research continues to grow and prosper this event contributes further towards the understanding of how they can be dealt with in a successful and cost effective manner.
This event offers an ideal platform for those who have recently moved in to respiratory studies as well as established professionals. This is an opportunity to network with the leading protagonists in the field and to learn from their knowledge and experience as well as to share your own.
Get full details about this report >>
|
US: 800.298.5699
Int'l: +1.240.747.3093
|
|
|
About MarketResearch.com
MarketResearch.com is an online aggregator selling over 400,000 market research reports,
company profiles and country profiles from over 720 research firms. Our reports will
provide you with the critical business and competitive intelligence you need for strategic planning and marketing
research. Coverage includes the US, UK, Europe, Asia and global markets.
|
